Takotsubo Cardiomyopathy
36
13
13
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.8%
1 terminated out of 36 trials
93.3%
+6.8% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (36)
Cyclosporine In Takotsubo Syndrome
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
The Broken Heart Study II (BHS-II)
Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
Registry of Patients With Takotsubo Syndrome
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Psychosocial Support for Patients With Takotsubo Syndrome
Prognotic Role of CMR in Takotsubo Syndrome
Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital
Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland
Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease
Beta-Blockers in Takotsubo Syndrome Study
Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)
Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) in Ischaemic, Inflammatory and Takotsubo Cardiomyopathy (MEMORY)
Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics
Characterization of priMary And sEcondary STress Related takOtsubo
Physical Exercise and Mental Wellbeing Rehabilitation for Acute Stress-induced Takotsubo Cardiomyopathy: The PLEASE Study
Life-style Interventions for Modulating the Brain Phenotype of Takotsubo Cardiomyopathy
Sympathetic and Vascular Function in Takotsubo Syndrome
Takotsubo Cardiomyopathy in Patients Suffering From Acute Non-traumatic Subarachnoid Hemorrhage